This study evaluates the effect of a new cognitive remediation program designed for patients suffering from a bipolar disorder, on cognitive functions, psychosocial functioning and neural processes. In this double-blind (patient, outcomes assessor) controlled randomized trial the investigators compare patients receiving the ECo program for bipolar disorders, to patients benefiting from the broadly used cognitive remediation program CRT and to patients receiving supportive psychotherapy. Patients are treated for 3 months and monitored for 9 months.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Enrollment
60
Unité de Recherche Clinique, EPS Ville Evrard
Neuilly-sur-Marne, France
RECRUITINGChange from baseline Perceptual Reasoning Index at 3 months
Composite score of the Wechsler Adult Intelligence Scale - fourth edition
Time frame: baseline and 3 months
Change from 3-months Perceptual Reasoning Index at 9 months
Composite score of the Wechsler Adult Intelligence Scale - fourth edition
Time frame: 3 months and 9 months
Working Memory Index
Composite score of the Wechsler Adult Intelligence Scale - fourth edition
Time frame: baseline, 3 months and 9 months
Processing Speed Index
Composite score of the Wechsler Adult Intelligence Scale - fourth edition
Time frame: baseline, 3 months and 9 months
Rey Auditory Verbal Learning Test
Neuropsychological test assessing verbal memory
Time frame: baseline, 3 months and 9 months
Cardebat's Verbal Fluencies
Neuropsychological test
Time frame: baseline, 3 months and 9 months
Emotion Hexagon
Task from the Facial Expressions of Emotion: Stimuli and Tests scale, assessing the recognition of emotions on faces
Time frame: baseline, 3 months and 9 months
Key Search Test
Task from the Behavioral Assessment of the Dysexecutive Syndrome scale, assessing planing abilities
Time frame: baseline, 3 months and 9 months
Stroop Color Word Test
Neuropsychological test assessing inhibition abilities
Time frame: baseline, 3 months and 9 months
Hamilton Depression Rating Scale
Time frame: 15 days before baseline, 3 months and 9 months
Young Mania Rating Scale
Time frame: 15 days before baseline, 3 months and 9 months
Functional Repercussions Scale
Self-assessment scale evaluating the consequences of cognitive impairments in daily life
Time frame: baseline, 3 months and 9 months
Social Desirability Scale
Self-assessment scale
Time frame: baseline, 3 months and 9 months
Social Relationships Scale
Self-assessment scale
Time frame: baseline, 3 months and 9 months
Self-Appraisal of Illness Questionnaire
Self-assessment scale
Time frame: baseline, 3 months and 9 months
Rorschach Inkblot Test
Time frame: baseline, 3 months and 9 months
Change from baseline Event-Related Potentials [ERP] P300 at 3 months during an Oddball task
Assessed for the first third of included patients
Time frame: baseline and 3 months
Change from baseline Event-Related Potentials [ERP] N2/P3 complex at 3 months during an emotional Stroop task
Assessed for the first third of included patients
Time frame: baseline and 3 months
Change from baseline serum Brain-Derived Neurotrophic Factor [BDNF] level (ng/mL) at 3 months
Assessed for the second third of included patients
Time frame: baseline and 3 months
Change from baseline functional Magnetic Resonance Imaging frontal activation at 3 months during an emotion recognition task
Assessed for the last third of included patients
Time frame: baseline and 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.